CAMBRIDGE, Mass. (AP) _ Voyager Therapeutics Inc. (VYGR) on Thursday reported a loss of $19.1 million in its second quarter.

The Cambridge, Massachusetts-based company said it had a loss of 50 cents per share.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 56 cents per share.

The gene therapy company posted revenue of $712,000 in the period.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VYGR at https://www.zacks.com/ap/VYGR

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News